Cytokines: Muscle protein and amino acid metabolism

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 1, 2012, Pages 85-91

  Van Hall, Gerrit ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Amino acids; Critical illness; Endotoxin; IL 6; Muscle breakdown; Muscle synthesis; Proteolysis; Sepsis; TNF

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MUSCLE PROTEIN; RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CANCER PATIENT; CRITICALLY ILL PATIENT; HUMAN; IN VIVO STUDY; INFLAMMATION; MUSCLE ATROPHY; NONHUMAN; NUTRIENT AVAILABILITY; NUTRITIONAL DEFICIENCY; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SEPSIS;

AMINO ACIDS; ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MUSCLE PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; WASTING SYNDROME;

ANIMALIA;

EID: 84857032651     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834e6ea2     Document Type: Review

References (54)

1. Lang CH, Frost RA. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor [alpha]. Metabolism 2007; 56: 49-57.
2. Vary TC. Acute oral leucine administration stimulates protein synthesis during chronic sepsis through enhanced association of eukaryotic initiation factor 4G with eukaryotic initiation factor 4E in rats. J Nutr 2007; 137: 2074-2079.
3. Kazi AA, Pruznak AM, Frost RA, Lang CH. Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis. Shock 2011; 35: 117-125.
4. Vary TC, Dardevet D, Grizard J, et al. Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. Am J Physiol Endocrinol Metab 1998; 275: E584-E593.
5. Orellana RA, O'Connor PMJ, Nguyen HV, et al. Endotoxemia reduces skeletal muscle protein synthesis in neonates. Am J Physiol Endocrinol Metab 2002; 283: E909-E916.
6. Murton AJ, Alamdari N, Gardiner SM, et al. Effects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium. PLoS One 2009; 4: e6945.
7. Biolo G, Fleming RYD, Maggi SP, et al. Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab 2002; 87: 3378-3384.
8. Gore DC, Wolf SE, Sanford AP, et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab 2004; 286: E529-E534.
9. Tjä der I, Rooyackers O, Forsberg A-M, et al. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 2004; 30: 266-275.
10. Klaude M, Mori M, Tjäder I, et al. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci 2012; 122: 133-142.
11. Dworzak F, Ferrari P, Gavazzi C, et al. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover. Cancer 1998; 82: 42-48.
12. Biolo G, De Cicco M, Dal Mas V, et al. Response of muscle protein and glutamine kinetics to branched-chain-enriched amino acids in intensive care patients after radical cancer surgery. Nutrition 2006; 22: 475-482.
13. Dillon EL, Volpi E, Wolfe RR, et al. Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clin Nutr 2007; 26: 736-743.
14. Biolo G, De Cicco M, Lorenzon S, et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008; 36: 1768-1775.
15. Fong Y, Marano M, Moldawer L, et al. The acute splanchnic and peripheral tissue metabolic responses to endotoxin in humans. J Clin Invest 1990; 85: 1896-1904.
16. Vesali RF, Klaude M, Rooyackers O, Wernerman J. Amino acid metabolism in leg muscle after an endotoxin injection in healthy volunteers. Am J Physiol Endocrinol Metab 2005; 288: E360-E364.
17. Vesali RF, Cibicek N, Jakobsson T, et al. Protein metabolism in leg muscle following an endotoxin injection in healthy volunteers. Clin Sci 2010; 118: 421-427.
18. Li Y-P, Reid MB. NF-kappa B mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1165-R1170.
19. Alvarez B, Quinn LS, Busquets S, et al. Tumor necrosis factor-[alpha] exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochim Biophys Acta Mol Cell Res 2002; 1542: 66-72.
20. Plaisance I, Morandi C, Murigande C, Brink M. TNF-{alpha} increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Am J Physiol Endocrinol Metab 2008; 294: E241-E250.
21. Williamson DL, Kimball SR, Jefferson LS. Acute treatment with TNF-{alpha} attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am J Physiol Endocrinol Metab 2005; 289: E95-E104.
22. Los VT, Haagsman HP. TNF-[alpha] inhibits adult fast myosin accumulation in myotubes. Cytokine 2006; 35: 154-158.
23. Zamir O, Hasselgren P, Kunkel S, et al. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992; 127: 170-174.
24. Goodman M. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol Endocrinol Metab 1991; 260: E727-E730.
25. Llovera M, Lopez-Soriano F, Argiles J. Effects of tumor necrosis factor-{alpha} on muscle-protein turnover in female wistar rats. J Natl Cancer Inst 1993; 85: 1334-1339.
26. Hoshino E, Pichard C, Greenwood CE, et al. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol Endocrinol Metab 1991; 260: E27-E36.
27. De Blaauw I, Eggermont A, Deutz N, et al. TNF-a; has no direct in vivo metabolic effect on human muscle. Int J Cancer 1997; 71: 148-154.
28. Warren R, Starnes H, Gabrilove J, et al. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987; 122: 1396-1400.
29. van Hall G, Steensberg A, Fischer C, et al. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 2008; 93: 2851-2858.
30. Petersen AM, Plomgaard P, Fischer CP, et al. Acute moderate elevation of TNF-a does not affect systemic and skeletal muscle protein turnover in healthy humans. J Clin Endocrinol Metab 2009; 94: 294-299.
31. Lang C, Frost R. Glucocorticoids and TNFa Interact cooperatively to mediate sepsis-induced leucine resistance in skeletal muscle. Mol Med 2006; 12: 291-299.
32. Clark MA, Plank LD, Connolly AB, et al. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis - a randomized, clinical trial. Crit Care Med 1998; 26: 1650-1659.
33. Metsios G, Stavropoulos-Kalinoglou A, Douglas K, et al. Blockade of tumour necrosis factor-{alpha} in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology 2007; 46: 1824-1827.
34. Toth MJ, LeWinter MM, Ades PA, Matthews DE. Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci 2010; 119: 467-476.
35. Goodman M. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994; 205: 182-185.
36. Williams A, Wang JJ, Wang L, et al. Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol Regul Integr Comp Physiol 1998; 275: R1983-R1991.
37. Llovera M, CarbóN, López-Soriano J, et al. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 1998; 133: 83-87.
38. Tsujinaka T, Fujita J, Ebisui C, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996; 97: 244-249.
39. Baltgalvis K, Berger F, Peña M, et al. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic mouse. Pflüg Archiv Eur J Physiol 2009; 457: 989-1001.
40. Timmerman KL, Lee JL, Dreyer HC, et al. Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelialdependent vasodilation and mammalian target of rapamycin complex 1 signaling. J Clin Endocrinol Metab 2010; 95: 3848-3857.
41. Gore DC, Chinkes DL, Wolf SE, et al. Quantification of protein metabolism in vivo for skin, wound, and muscle in severe burn patients. JPEN J Parenter Enteral Nutr 2006; 30: 331-338.
42. Gore DC, Wolfe RR, Chinkes DL. Quantification of amino acid transport through interstitial fluid: assessment of four-compartment modeling for muscle protein kinetics. Am J Physiol Endocrinol Metab 2007; 292: E319-E323.
43. Biolo G, Ciocchi B, Lebenstedt M, et al. Short-term bed rest impairs amino acid-induced protein anabolism in humans. J Physiol 2004; 558: 381-388.
44. Fong Y, Marano M, Barber A, et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1989; 210: 449-456.
45. Webster NR, Galley HF. Immunomodulation in the critically ill. Br J Anaesth 2009; 103: 70-81.
46. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
47. Chen Q, Li N, Zhu W, et al. Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats. J Inflamm 2011; 8: 13.
48. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949.
49. Ferrando A, Stuart C, Sheffield-Moore M, Wolfe R. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 1999; 84: 3515-3521.
50. Elijah IE, Branski LK, Finnerty CC, Herndon DN. The GH/IGF-1 system in critical illness. Best Pract Res Clin Endocrinol Metab 2011; 25: 759-767.
51. Smith IJ, Alamdari N, O'Neal P, et al. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Int J Biochem Cell Biol 2010; 42: 701-711.
52. Hartemink KJ, Groeneveld ABJ. The hemodynamics of human septic shock relate to circulating innate immunity factors. Immunol Invest 2010; 39: 849-862.
53. Ellis C, Jagger J, Sharpe M. The microcirculation as a functional system. Crit Care 2005; 9: S3-S8.
54. Georger J-F, Hamzaoui O, Chaari A, et al. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by nearinfrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 2010; 36: 1882-1889.